跳至主要内容
临床试验/NL-OMON53162
NL-OMON53162已完成2 期

De behandeling van Rosacea met Oxofulleram. Een pilotonderzoek naar de klinische toepasbaarheid van Oxofulleram. - Solenne-OxoF-Rosa

Solenne BV0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - a diagnosis of papulopustular rosacea;
  • - the conventional treatments of rosacea should be stopped with a wash-out period of one month;
  • - age 18-65 years;
  • - male and female;
  • - women of childbearing age use double barrier contraception

排除标准

  • - Patients with non papulopustular subtypes of rosacea are excluded from the study;
  • - Patients with other facial dermatoses (acne, perioral dermatitis, eczema);
  • - Age: younger than 18 and older than 65 years;
  • - Pregnancy;
  • - Patients treated with an EGFR inhibitor for an oncological condition are excluded from the study;
  • - Legally incapable.

研究者

发起方
Solenne BV

相似试验